INTRODUCTION: THE FALL OF HOMO ECONOMICUS AND THE RISE OF TECHNOCRATIC RISK REGULATION
A substantial body of research suggests that lay perceptions of risk are rooted more in cognitive heuristics than in reason; homo economicus is no longer with us. (2) (3) (4) In short, when forming judgements under uncertainty people often answer complex, time consuming
questions (e.g. what is the risk posed by nuclear power?) by substituting them with simpler ones (e.g. how do I feel about nuclear power?). Although such heuristics are argued by some to be efficient and often accurate tools for dealing with bounded rationality, (e.g. 5) the focus of the risk regulation literature has been on the systematic and predictable errors that arise from their application. (4, (6) (7) (8) (9) The concern is that such e o eous isk pe eptio s a e replicated in law, policy and regulation, as democratic governments respond to the (mis)fears of the citizenry. This has catalysed an influential school of thought which prescribes a relatively technocratic approach to regulating risk, characterised by a high degree of deference to formal risk and cost-benefit analysis in the policy-making process.
(e.g. 4, [10] [11] [12] [13] These ethodologies a e i te ded to se e as i stitutio al safegua ds (8) that screen out the malign influence of heuristic-based judgments, and thus help ensure rational risk regulation (i.e. utility maximising). In short, the argument is that e e if a y heuristics mostly work well in daily life, a sensible government can do much better than to rely on the . (Sunstein, 2002 (4) ) This school of thought -and its close cousin the Nudge agenda (14) -has intimately shaped policy debates and practices throughout the West.
Nevertheless, the basic argument has been challenged on a variety of fronts. It has been:
critiqued as paternalistic or even undemocratic, in that it fails to respect citizen preferences; (15) portrayed as placing too much emphasis on the role of heuristics and biases in shaping risk perceptions to the neglect of factors such as culture; (16) and accused of downplaying the value judgements embedded within technical analysis. Yet the overarching premisethat reliance on risk and cost-benefit analysis is a viable means for screening out heuristic influences from risk regulation -remains broadly unchallenged. To be sure, several scholars (e.g. 17) have emphasised that risk assessors are unlikely to be free of cognitive quirks, yet this tu quoque argument rather misses its target. After all, Sunstein and his fellow travellers are not suggesting that policy-making should rely on expert perceptions of risk, but on expert analyses. For a tu quoque argument to have any force, it must be directed at the methodology and practice of formal risk assessment, not at how experts perform in psychometric tasks.
Through two studies of chemicals regulation, this paper takes up that challenge. It shows that the technical assessment of risk is structured and pervaded by its own set of heuristics, which are used to categorise potential threats, define what constitutes valid data, guide causal inference, and select and apply formal models. Some of these heuristics lay claim to theoretical or empirical justification, others are more back-of-the-envelope style calculations, whilst still more purport not to reflect some truth but simply to constrain discretion or perform a sort of desk-clearing function. The tu quoque critique turns out to have some mileage, although in a different direction than initially conceived. Of course, a collective reliance on heuristics does not imply that lay and expert analyses of risk are on the same footing, at least if we are to take the idea of expertise at all seriously. Indeed, the central theme of the paper is that heuristics are not problematic per se -induction necessarily depends on procedures of inference that cannot be fully justified in a formal sense (18) -but rather that they have certain structural features that carry significant implications for how we think about and design risk assessment processes.
We emphasize that the heuristics we identify are rather different in character from the lay rules of thumb à la Danny Kahneman, (e.g. 2) which are intuitive, fuzzy (i.e. based on linguistic rather than mathematical terms), and domain-general. Our rules have more in common with another school of thought on heuristics, which traces its (modern) origins to the work of Polya. (19) Polya saw heuristics as provisional methods and principles of discovery that fell short of demonstration, yet that were indispensible for domains that did not admit of formal logic or proofs. His notion of heuristics heavily influenced the (then) emerging fields of artificial intelligence and expert systems, including pioneers such as Simon, (20) Pearl (21) and Lenat. (22) In these fields, heuristics are conceived and modelled as one of the foundational elements of expert knowledge. They are generally represented as sets of ifthen rules that guide and structure inferences, decisions, and problem-solving in systematic ways. Their functions range from interpreting data, to predicting system behaviour, and to system control. (23) These sorts of rules are typically domain specific rather than general purpose, often represented in formal language rather than linguistic variables, and work by leveraging empirical facts or causal relations that are more or less accepted or understood.
Although they do not guarantee correct solutions or optimal outcomes, they offer useful guidance through drawing on incomplete or imperfect knowledge and making problems 6 tractable (e.g. through ignoring information or options). These basic properties -formalism, domain-specificity, a focus on induction rather than proof, and explicit justificationsuggest that this tradition is a useful framework to bring to the analysis of technical or expert practices such as formal risk assessment. And so we draw on some of its key insights.
Our pape 's ain contribution is to show that by studying the heuristics of risk assessment qua heuristics -that is, by thinking about the particular justifications, functions, and problems of rule-based reasoning -we develop important insights on the form, strengths, and limits of the prior art. Put another way, it offers a novel representation of the methods, conventions, and biases of formal risk assessment, and one that offers practical insights on how to improve this crucial process. The body of the paper is split into two parts. Study I offers a detailed but largely theoretical analysis of the heuristics that structure the United "tates E i o e tal P ote tio Age 's EPA isk assess e t ethodolog fo i dust ial chemicals. Study II offers a brief empirical proof of concept that such heuristics are applied and interpreted in significant and interesting ways across various policy domains, drawing on judicial reviews of agency decisions.
STUDY I: METHODOLOGY

Case Selection and Rationale
This section of the paper examines the risk assessment of industrial chemicals, focussing on the practices of the EPA. The main logic of this choice was that the four-stage chemical risk assessment paradigm (Figure 1 ) -or its close cousins -underpins a range of policy-domains (e.g. pharmaceuticals, food additives, hazardous waste site evaluations, microbiological risk assessment, etc.), and so the findings would lend themselves to generalisation. The second logi as that the EPA's p a ti es a e elati el transparent and well documented. Thirdly, the EPA has pioneered risk assessment across a range of environmental and public health do ai s, a d so a e see as so ethi g of a ha d ase f o hi h to uild the thesis.
Broadly speaking, the aim of the research was to uncover and critically evaluate the heu isti s e edded ithi the EPA's app oa h to hemical risk assessment. The narrow goal was to question the claim that a sensible government can do better than rely on rules of thumb, although the broader ambition was to develop insights into the practice of risk assessment by studying those rules qua rules.
Methods and Definitions
Data was collected from various sources describing, evaluating, and providing context or a kg ou d o the EPA's p a ti es, i ludi g: a isk assessment statutes, guidelines, procedures and outputs; b) critiques and evaluations of those practices from within the scientific and policy communities; and c) primary research papers and reviews providing detail and background on the relevant theories, methods, and assumptions adopted by the agency. The data was then inspected to identify the heuristics embedded within the risk assessment process. The heuristics were next grouped into categories according to the functions they performed (e.g. causal inference, weighting lines of evidence, etc.). Heuristics are defined here as rules of thumb for inference and choice. There are three key elements to this definition: heuristics are rule-like, in the sense that there is a presumption in favor of following them (i.e. they structure or constrain judgment); they are rules of inference or choice (i.e. if-then), not simply assumptions; and finally, they are simple, frugal approaches to problem solving which ignore relevant information rather than seeking to optimize.
Although heuristics are treated rather differently across and even within different disciplines -in terms of their normative status, where they reside, and whether they are implicit or explicit -this definition seems to capture a shared understanding of what they are. As we are concerned with the practice of technical risk assessment it should be clear that we do not -in contrast to the mainstream risk literature -see heuristics solely as intuitive tools residing primarily at the subconscious level. Instead, our focus shall be on those heuristics that are socially and scientifically constructed, reside within institutions, and are applied deliberatively.
STUDY I: RESULTS AND DISCUSSION
This section places the heuristics identified within the context of a functional typology, and includes discussion of their basic form, origins, and characteristics.
Screening and Categorisation Heuristics
Context and Heuristics
A basic problem in chemicals regulation is that not all substances of potential regulatory interest can be subject to comprehensive risk assessment, and so some approach has to be devised to search and prioritise the problem space. 
Analysis
These heuristics can be seen as an attempt to codify a body of knowledge and to leverage it in a way that reduces the problem space to a more tractable size, and avoids repeat enquiries into similar facts. The rules draw on two different sorts of justifications. The first is to use the identifying properties of a class to categorise chemicals into groups (e.g. using the existence of particular functional groups to classify substances). The second sort involves causal knowledge, for example relating to how particular properties of chemicals (e.g. functional groups) shape environmental and biological behaviour. Often rules draw on both types of justification. For example, the second rule uses the threshold of > 1,000 daltons as the identifying property to class a substance as heavy. And it is also based on causal assumptions, namely that heavy polymers are unlikely to reach molecular receptors or other target tissues, and that highly reactive chemicals (strong mineral acids and bases) will destroy tissue at the point of entry leading to toxic effects other than through the endocrine system. (25) On the other hand, these heuristics also emerged under pressure from the regulated industry and the courts, who had called for greater predictability, transparency, and consistency in the prioritisation process. (26) From this perspective, the rules serve to discipline the process and make it explicit. Heuristics, then, can have multiple origins or types of justifications: ways of justifying specific rules, and also ways of justifying rules qua rules.
However, these rules -by virtue of being generalisations -may lead to misclassification in certain instances. Consider the first decision tree. Here, the criterion for classifying chemicals as e bioaccumulative or not (> 5000 BAF or BCF) is based on the logic that BCF and BAF are proxies for the potential for a chemical to accumulate within organisms and concentrate up the food-chain. Although this generalisation has theoretical and empirical verification, it stems from work on lipophilic, non-ionic, organic substances that undergo minimal metabolism. (27) For substances that do not share those properties, BCF or BAF may not be reliable indicators for bioaccumulation (e.g. chemicals where sorption does not depend on hydrophobic interaction). These, then, are the scope conditions under which the heuristic is valid, and by explicitly stating them -in apparent contrast to other regimes (28) -the EPA guards against misclassification. This cannot, however, skirt the arbitrariness inherent in using thresholds to classify chemicals according to interval (rather than categorical) variables, a problem compounded by the often substantial uncertainty surrounding measurements of these properties.
Gatekeeping Heuristics
Context and Heuristics
A key challenge of risk assessment is to winnow down the mass of data that might serve as inputs to the process, whether relating to a he i al's to i ologi al ode of a tio , the form of its dose-response curve, or its environmental fate and behaviour. Two evaluation tests are generally applied: is the data relevant, and is it of sufficient quality/validity; our focus is on the latter. One approach to this evaluation is to establish rules for excluding studies deemed to be wholly inadequate in protocol, conduct, or reporting (i.e., gatekeeping rules). For example:
 EPA risk assessors are encouraged to exclude toxicity studies whose test protocols use either excessively or insufficiently high dose selections, according to specified criteria (e.g. if neither toxicity nor weight gain is observed in the test population, then the maximum dose is generally considered to have been insufficiently high). (29) However, such a rule-like approach to determining technical validity is very much the exception at the EPA. This is likely due to the rise of weight-of-evidence approaches in the age 's approach to risk assessment, and the associated principle that even imperfect studies might serve as inputs, albeit with appropriately low weights. This brings with it a focus on weighting the quality or strength of different lines of evidence, rather than a reliance on categorical tests for accepting or rejecting data. However, one long-established and highly significant gatekeeping rule resists this Zeitgeist:
 Toxicity studies funded or conducted by industry are deemed invalid for regulatory purposes if they do not adhere to Good Laboratory Practices (GLP) and EPA approved test methods (the GLP heuristic ).
This heuristic plays a rather more complex function than simply discriminating between valid and invalid research, as we see below.
Analysis
The GLP heuristic acts to exclude, for the purposes of risk assessment, industry toxicity studies that do not conform to the mix of general quality requirements and technical prescriptions contained in GLP and the relevant test methods (e.g. covering the care of laboratory animals, instrument calibration, test protocols, and the collection and storage of raw data). Crucially, the principle is not that studies which do not conform to these requirements are necessarily invalid, as can be seen from the fact that it applies only to industry rather than academic research. Indeed the concept of GLP emerged in response to sloppy research practices, research misconduct, and even outright fraud on the part of private research companies operating free from the checks and balances of academic peer review. (31, 32) And so the GLP heuristic was intended as a way of controlling any incentives that industry might have to downplay the risks associated with their products, and to serve as a surrogate for peer review to ensure a basic level of methodological quality. Yet the rule carries with it some unintended consequences. For example, given that the approved test methods are subject to detailed validation and interlaboratory reliability studies, they may come to represent relatively insensitive and outdated methodologies when compared to cutting edge or novel research techniques or protocols. (33) In such instances, the heuristic can serve to ensure that industry studies do 't follo state-of-the-art methods, and so might impede the resolution of questions that lie at the centre of risk assessment controversies. (32) Citing concerns about the reproducibility and validity of research conducted via nonstandardized methodologies, some toxicologists (including industry scientists) have implied that academic research should be subject to the same GLP heuristic. (33) The explicit claim is that only GLP compliant work is sufficiently robust and rigorous to serve as a basis for quantitative risk assessment.
(e.g. 34) This has been fiercely resisted by some scientists -on the grounds of the high costs of compliance, the fact that academic peer review acts as an analogous (or superior) form of quality control, and the concern that it would exclude novel experimental designs from consideration in risk assessment. (32) The defence, in short, is that such a scope-extension would have little basis in the original justification of the heuristic, and that in some instances, it may represent a strategic effort on the part of industry to exclude research that may threaten their commercial interests (i.e. an attempt to game or bend the rule). Whatever the merits of this dispute, these efforts at scope-extension appear to have found isolated success in other policy domains, with the US Food and Drug
Administration's recent evaluation of BPA excluding academic toxicology studies that were not GLP-compliant.
Causal Inference
Causal inference is broadly concerned with determining whether an association should be treated as causal (i.e. t ue , rather than as non-existent or spurious. It can be classed into two categories depending on whether it focuses on the interpretation of a discrete signal, or on the weighting and aggregation of multiple lines of evidence. At the EPA, variants of this rule are used to:
 Determine whether chance, rather than a treatment-related effect, is a plausible explanation for an apparent increase in tumour formation (during hazard identification); (29)  Inform the derivation of the no-observed-adverse-effect-level (NOAEL) in doseresponse analysis (a statistically significant response is sufficient, but not necessary, to reject an exposure level as representing the NOAEL); (35) and  To discriminate between t ue dete tio s of a chemical substance (analyte) and detections that cannot be reliably distinguished from instrument error or noise (i.e.
the limit of detection). (36) 3.3.1.2. Analysis
The statistical significance heuristic is a long-standing and controversial approach to causal inference. General critiques of its application within risk assessment have centred on: (37, 38) 1) The fact that it focuses entirely on statistical considerations to the neglect of other relevant factors;
2) The arbitrariness of (typically) selecting a p-value of 0.05 as the threshold that demarcates t ue f o false asso iatio s (i.e. that it is a mere convention); and, In other words, it is not just the content or form of the heuristic that has been seen as problematic; instead, it has been criticised as a rule. That is, it has been critiqued as neglecting information that often turns out to be crucial, portrayed as being ritualistically and uncritically adhered to, and attacked as having been adopted in a context where its original justification no longer holds true. These are all general critiques of rules qua rules.
However, the third element of this critique -the ha ge of o se atis -has limited t a tio he e the EPA's p a ti es a e o e ed. This is because, for the three variants of the rule listed above, a failure to meet the threshold of statistical significance does not mean that the finding or association is treated as chance or as noise (which would err on the side of under-estimating risk). For example, in exposure assessment, where observed values (concentration levels) are deemed to be too low to be reliably distinguished from instrument error or noise, they are not treated as zero. Instead, procedures are applied to su stitute fo this e so ed data (e.g. proxy measures are used), to guard against underestimation. (36) This is broadly analogous to what Pearl (21) alled e o e s he essafegua ds uilt i to a heu isti 's appli atio desig ed to e su e that it does 't fu tio i perverse or undesirable ways. This suggests a fairly subtle appreciation of the biases that are intrinsic to rule-based reasoning. Although, as we shall see, this appreciation is sometimes lacking.
Weight of Evidence Heuristics
Weight of evidence (WoE) approaches are increasingly prominent at the EPA, following the logic that there are often multiple lines of evidence that bear on a particular causal inference (e.g. is a chemical a human carcinogen), which need to be weighted and aggregated prior to making a final determination. This process may in principle be guided by some formal algorithm or set of rules (as proposed in (39) ), though in practice typically takes the form of factors-based judgments. A classic example is Bradford-Hill's list of criteria for determining whether a chemical causes disease in a given population, variants of which are set out across EPA guidelines. Here, the factors to be considered in interpreting evidence are pre-defined (e.g. the strength of any epidemiological association, its biological plausibility, etc.), yet generally without rules for weighting or summing them.
(e.g. 29) As an exception to this rulelessness, the agency has set out heuristics that classify the relative strength of different sources of animal and epidemiological evidence:
 In evaluating whether a chemical is potentially mutagenic, the agency places greater weight on tests conducted in germ cells than somatic cells, on in viva rather than in vitro tests, on tests in eukaryotes rather than prokaryotes, and on mammalian rather than sub-mammalian species.
 A similar set of rules exists to guide the evaluation of potential endocrine disruptors (e.g. in vitro results from assay systems with metabolic capacity outweigh results from those without, etc.). (41, 42)  In cancer risk assessment, human data is given greater weight than animal data in hazard characterization and dose-response assessment (provided it is of high quality and adequate power), and amongst epidemiological studies, greater weight is given to those having more specific and precise exposure estimates. (29) -sufficiently clarify this point. This is not an issue restricted to evidence hierarchies. It is the broader problem of clarifying the nature and extent of evidence required to depart from heuristics in particular instances. We return to this later.
The latter hierarchy is based on the statistical properties of the study outputs, the idea being that studies with high precision (or low variance) are more informative (e.g. typically having larger sample sizes, etc.).
Modelling
The heuristics discussed so far have dealt with tasks of classification; we now turn to heuristics involved in the selection and application of dose-response models, looking at both carcinogens and non-carcinogens (Figure 2) , and focussing on the use of animal rather than epidemiological data. The EPA adopts different modelling approaches for interpolation and extrapolation, so we address each separately before providing a joint analysis.
Interpolation (analysis in the observed range)
Context and Heuristics
The determination of a (potential) causal link between a chemical and harm is the precursor to building formal models of the relationship between dose and response. Interpolation involves structuring and regimenting the raw test data into a dose-response curve (typically covering moderate-high dose levels), with the purpose of de i i g a poi t of depa tu e (POD) from which extrapolation to the low-dose range can then be made. (35, 43, 44) This is a complex task with numerous possible approaches. For example, which species and endpoint should be used as the basis for the dose-response relationship? Should a biological or statistical model be used for interpolation? And which parameter estimation technique should be used to apply it (e.g. maximum likelihood vs. non-linear least squares)? Or should the dose-response data simply be plotted by hand, and formal modelling eschewed (e.g.
where the NOAEL or LOAEL are taken as the POD)? These are the classic dilemmas of modelling-for-policy, where model selection is typically underdetermined by the raw data, underlying theories may be contested, and any choice involves a mixture of science and policy judgment. Rather than leave these decisions entirely up to the discretion of risk assessment teams, the EPA is famous for having adopted presumptive rules to structure the process. (43) (44) (45) One such rule, generally perceived to be precautionary, is that:
 The iti al effe t is the preferred basis for constructing the dose-response model, in situations where there are several datasets to choose from (e.g. datasets relating
to different endpoints, such as carcinogenic vs. neurotoxic, and perhaps of different species). (35) Moreover, there are simple rules applied to adjust dose-response data prior to model construction:
 The cross-species scaling heuristic for oral exposure, § wherein animal doses are scaled by ¾ power of body-weight to derive the toxicologically equivalent human dose (to account for differences in size and lifespan across species); (46) and  A special-form of Ha e 's Rule -where identical products of dose concentration and exposure time are presumed to lead to equivalent biological responses (C × t = k) -is used, where necessary, to adjust from intermittent laboratory exposu es to eal o ld o ti uous e posu e o ditio s. (47, 48) The above two are rules setting out how to adjust the raw dose-response data, and are empirically rooted in the sense that they purport to represent relationships that exist in the real-world, rather than being justified on policy grounds. They embody truth claims, in other words, rather than being mere conventions or value judgments, and these claims can be
The first adverse effect, or its known precursor, that occurs to the most sensitive species as the dose rate of a age t i eases. § This applies to carcinogenic risk assessment (Figure 2 ). For non-carcinogens, cross-species extrapolation is achieved through applying an adjustment factor (discussed later), although the EPA has recently moved to harmonise the two. Pharmacokinetic modelling is an alternative approach to cross-species scaling, although rarely possible in practice.
held to account. Accordingly, their empirical bases have been subject to critical scrutiny, (46, 48) and indeed one long-sta di g iti ue of Ha e 's Rule is that it has at ti es ee interpreted by toxicologists as a causal law, rather than as a statistical approximation subject to certain scope conditions. (49) We now turn to model selection and implementation, which is largely a curve-fitting exercise, in the sense that there is typically little mechanistic basis to the models being considered.
(50) For model implementation -or parameter estimation -the EPA relies on factors-based judgments rather than explicit rules. For example, the factors that may influence the selection of parameter estimation techniques are discussed in the more technically-oriented guidelines, (e.g. 50) although no default method is established, nor is a rule or algorithm established for choosing between them. For model selection, the EPA tends not to rely on default procedures per se. ** That is to say that there is typically no default model recommended, nor an explicit hierarchy of preferred models, in part because different study designs and datasets shape dose-response patterns. (50) But the agency does use heuristics to guide the process of model selection. (50)  In benchmark dose-espo se odelli g, α = . is e o e ded as easu e of adequate fit, alo g ith a less fo al e e alli g test.
 Should multiple models pass the above tests, the minimum score on a measure that balances complexity with fit -Akaike's I fo ation Criterion (AIC) -is recommended to select the best model.
Extrapolation (analysis outside the observed range)
** An exception is that the multi stage model is the preferred approach to analysing cancer bioassay data, which is a relatively flexible modelling framework.
Context and Heuristics
Extrapolation involves the construction of new data points, and, in our context, refers to analysis in the low-dose region. It is the most significant stage of the modelling process, as the low-dose region is relevant to real-world human exposure levels and is thus the basis for regulatory decisions. Perhaps the most controversial heuristics are those guiding the selection of model structure at low doses:
 If a chemical is carcinogenic, then a linear non-threshold dose-response model is adopted. The exception to this rule is cases where a) the he i al's mode-of-action is established and b) that mode of action is thought to be non-linear at low doses (e.g. cytotoxicity);
 If a chemical is non-carcinogenic, then a threshold dose-response model is applied (i.e. below a certain exposure, no response is expected).
The non-threshold linearity assumption for carcinogens originated in radiation biology, and -although there are of course significant differences in how the two types of exposure are absorbed by and interact with organisms -was later mapped across to chemicals regulation. (51) This was on the grounds that it was both theoretically plausible -the idea being that e e a si gle ole ula e e t a i itiate alig a t o eoplasti ell t a sfo atio , a d so might lead to cancer -and likely to be health protective. (51) By contrast, the presumption of a threshold for non-carcinogens follows the idea that below a certain dose, clearance pathways, cellular defences, and repair processes can minimize damage and thus render exposure practically negligible.
(44) However, these rules have been critiqued for retaining a certain ambiguity about when they can be overturned, which we return to later.
The above, then, are rules for selecting the fundamental assumptions or basic structures of the models to be adopted. Let us now turn to rules for applying those model structures to the data. In linear extrapolation, the goal of the modelling exercise is to derive the slope of the dose-response curve, as this (combined with exposure) is the basis for the subsequent risk estimate. The relevant heuristic is as follows:
 The slope is derived by simply drawing a straight line from the point of departure (POD) to the intersect of the two axes, correcting for background.
By contrast, for threshold models, the goal is to de i e a safe le el of hu a e posu e i.e.
the threshold for humans, known as the reference dose or reference concentration). This is done through applying a series of uncertainty and adjustment factors (conventionally a value of 10 is used for each, where applicable) to the POD to account for: (52)  Inter-species variability;
 Variations in susceptibility within the human population;
 The difference in sensitivity between chronic and sub-chronic toxicity studies (in the case where sub-chronic studies are the basis for deriving a threshold for a chronic effect);
 The difference between LOAEL and NOAEL (if LOAEL is used as the POD); and  Gaps or uncertainties in the toxicity database.
These safet factors are essentially back-of-the-envelope style heuristics designed to accommodate the various forms of uncertainty -both in terms of variability and ignoranceand adjustments required to extrapolate from the findings of a specific laboratory protocol
Model-based approaches to low dose extrapolation may also be performed (e.g. in biologically based dose response modelling), but theoretical and empirical limitations generally preclude this. There exist a rich range of modelling heuristics, from those selecting what is to be modelled in the first instance (e.g. which endpoint, which species), to those adjusting or laundering the raw data to make it fit-for-purpose (e.g. adjusting measures of exposure), and even those selecting the fundamental assumptions (e.g. threshold vs. non-threshold) and specific functional form of the model to be applied. Of course rules being rules, they inevitably will have their exceptions, yet one major issue is the lack of clarity about what sort of evidence, and how much, is required to depart from them. This has led to several instances when the EPA has been reluctant to depart from them their heuristics even in the face of substantial contradictory empirical evidence. For example, the agency retained the default linear approach to low dose extrapolation in its risk assessment of dioxin, despite clear evidence suggesting that the substance promoted cancer via receptor-mediated pathways that are by nature non-linear. (53) This not only led to a skewed estimate of risk, but also understated uncertainty, as the assessment failed to explore how departing from this particular default would have influenced the analysis outcomes. The very same problem -a lack of clarity on hat o stitutes suffi ie t sho i g fo depa tu es -is found with the default safety factors. (54) And again, this ambiguity has led EPA risk assessors to rigidly adhere to the default values in cases, such as with dioxin and formaldehyde, where a wealth of data seems to justify departing from them and using chemical-specific adjustment factors. (54) A second common thread is the tension between adopting heuristics that have a reasonable theoretical and empirical basis on the one hand, and the desire to have rules that are health protective on the other. This is a conflict lying at the heart of many debates over method and policy in risk regulation -when does it make sense to attempt to regulate on the basis This has led the EPA to articulate (in different levels of detail) the circumstances or evidence that might justify departures from some rules generally perceived to be precautionary (e.g. specifying the factors that may justify using the species that most resembles humans as the basis for dose-response modelling, rather tha the iti al effe t ), and to establish one other reform that holds particular conceptual interest: (52)  A safeguard against the excessive compounding of uncertainty and adjustment factors has been established -specifically, they must not combine beyond a value of 10,000 in deriving the safe level of human exposure. ¶
The above has some parallels with Pea l's otio of e o e s he es, which traditionally serves as an es ape al e from the rigid application of rules when they are perceived to lead in unhelpful or perverse directions. However, in the above case, the logic is that a compounding of factors to 10,000 and beyond -whilst sometimes required by a strict interpretation of the rules -would lead to significant e agge atio s of the t ue isk posed by the chemical. And so the distinction is that departures from the rules are justified out of concern for the interaction of rules, rather than a concern with rules operating in isolation. This is distinct from the usual scope restrictions a d e o e s he es that come with heuristics, and suggests the importance of analysing heuristics as systems or chains of rules, rather than merely as independent objects.
(c.f. 56)
Also worth reflecting on is the distinction between the EPA's mix of factors-based guidance and heuristics for selecting and applying models for interpolation of the dose-response data, compared to the rather more prescriptive and rule-bound approach to extrapolation. In extrapolation, heuristics set out the default model structures to be adopted, and set out in detail the particular rules to be followed in implementing those models. In contrast, in interpolation, model implementation is factors-based rather than rule-bound. And model selection is a mixture of clear rules and informal tests (e.g. e e alli g . And the rules focus on the processes by which models should be selected (e.g. measures of goodness of fit and AIC), rather than prescribing particular outcomes (i.e. default models). At first glance this contrast appears surprising or perhaps even incoherent, as the low-dose region is the very area in which theories are most contentious and data largely lacking. Yet an explanation comes to light when we consider that alternative plausible approaches to low dose extrapolation lead to risk estimates that may differ by several orders of magnitude. (57) In other words, the analysis outcomes are particularly sensitive to the choices made during extrapolation, rather than interpolation. The assumption and model-laden nature of extrapolation, and the extent to which it determines outcomes, has long been recognised.
And given the general lack of scientific agreement over the most appropriate assumptions, it historically fed concerns about both inconsistency in risk assessment, and that outcomes may even be tailored to meet policy objectives. (54) And so the introduction of ruleness in this case appears to represent not so much an attempt to codify or formalise existing (albeit provisional) bodies of knowledge, nor simply a desire to err on the side of precaution, but rather an attempt to narrow or constrain the inferences open to risk assessors, and thus enforce a degree of consistency, transparency, and predictability in both process and outcomes. Critics argue that this pursuit of consistency has brought with it blindspots, such as the neglect or marginalisation of low-dose phenomena that do not cohere with the extrapolation rules (e.g. hormetic responses characterised by low-dose stimulation and high-dose inhibition, (58) and postulated mechanisms of endocrine disruption where conventional dose-response assumptions are held to be invalid (59) ). The claim here is not just that rules have exceptions, but that they can become entrenched in ways that make it difficult to displace or circumvent them in practice. For example, as a consequence of the very existence of the low-dose extrapolation rules -and the way that they shape the underlying paradigms of toxicity testing -there is rarely case-specific evidence available to question or indeed support their validity (i.e. empirical data within the low-dose region is simply not part of conventional test requirements). On this reading, rules can shape practices in the real world in ways that make it less likely for them to be challenged.
STUDY II: PROBLEMS WITH RULES IN PRACTICE
The foregoing analysis has is in a sense been largely theoretical, focussed more on the content, structural features, strengths and potential problems of the heuristics of risk assessment, rather than on how they are interpreted and applied in concrete settings. We now turn to make the case that some of those structural features and potential limitations play out in real-world settings in interesting and important ways, and that this is not an issue restricted to industrial chemicals regulation. We do so by analysing six cases of judicial review of regulatory risk assessments in the United States, in policy domains ranging from air pollution, to water quality standards, to waste management. We identified these cases through entering various search strings intended to reflect or relate to our previously discussed expert heuristics (e.g. isk assess e t AND default assu ptio s; isk assess e t AND safet fa to s ), and scrutinizing the results for relevance. The idea was not to recover a comprehensive listing of all such disputes, but rather to identify those cases which had turned i sig ifi a t easu e o the egulato age 's appli atio o interpretation of heuristics.
The particular disputes recovered focussed on such things as the application of default model structures, on the use and neglect of safety factors, and on the reasoning behind departing from hierarchies of evidence (Table 1) . They reveal instances of the unthinking reliance on rules, such as when an emission standard for an air pollutant was based on a default model that assumed the substance to be a gas, when in fact it was known to be a solid at the relevant temperatures. They highlight examples of the dubious interpretation of rules, such as where the EPA relied on ad hoc justifications to retain the default linearity assumption in modelling the risk of a carcinogen, despite having earlier concluded that it followed a nonlinear mode of action (cytotoxic rather than genotoxic). They show instances of unreasoned departures from rules, such as where the EPA and OSHA failed to justify deviating from safety factors designed to account for sensitive populations, which again highlights the da ge s of ot la if i g hat o stitutes suffi ie t sho i g fo depa tu es.
And they point towards the interpretive flexibility associated with linguistically defined rather than mathematical rules, such as in the dispute over whether a particular toxicology experiment was unethically conducted and so should not be relied on. Taken as a whole, the cases show that heuristics play important roles in risk assessment across various policy domains, that they are sometimes applied or interpreted in problematic and contested ways, and that authoritative actors (e.g. courts) take these issues seriously.
CONCLUSIONS
Psychological research has cast doubt on the idea that laypeople use formal logic or statistical approaches to reason about risk issues, suggesting instead that they rely on simple and error-prone rules of thumb. Many scholars have drawn a sharp-distinction between this heuristic-reasoning and the rigour and reliability of formal risk assessment, and by extension called for relatively technocratic approaches to risk regulation as a way of ensuring that policies conform to rational ideals. (1, 4, (7) (8) (10) (11) (12) (13) Yet as we have seen here, formal risk assessment is structured and pervaded by its own set of heuristics. As a preliminary typology, we distinguished between classification rules that inform priority setting and test strategies; gatekeeping heuristics that filter problematic studies away from the risk assessment process; rules that structure and guide causal inference; and heuristics for model selection and application. Some of these rules lay claim to empirical or theoretical justifications, whilst others are more back-of-the-envelope style estimations, and still more serve policy goals beyond that of simply codifying knowledge. This is not to imply an equivalence between lay and expert risk assessment. Instead, we have tried to suggest that significant aspects of risk assessment can be represented as heuristics, and to use this insight to work towards a useful analytical framework for characterising the process.
Put another way, our basic argument is that by analysing the rules of risk assessment qua rules, we generate important insights about the nature, strengths, and limits of the prior art, and insights that offer practical ways of improving it. We suggest that the heuristics of risk assessment are not just an unruly collection of tools. When viewed as an approach to governing risk assessment, heuristics serve to close down or constrain interpretive possibilities, thus conferring a modicum of stability, consistency, and transparency upon a process that might otherwise be (seen as) highly sensitive to the choices of individual analysts. They can be understood as a way of authenticating or formalising risk assessment as a scientific practice, (60, 61) representing as they do a series of rules for bounding problems, collecting data, and making sense out of it (i.e. a methodology). There are, of course, substantive critiques of heuristics qua rules, including that they generate systematic error, may create a veneer of consistency by masking uncertainties, can be manipulated for strategic purposes, and have a tendency to become entrenched. These critiques can be partially offset by ensuring that the scope conditions of rules are specified, that the nature and extent of evidence required to justify a departure from them are made clear, that programs exist to periodically re-evaluate the empirical and theoretical support of particular heuristics, that recovery schemes are in place to correct for when they go awry, and that es ape al es a e i pla e to guard against perverse outcomes stemming from the interaction of rules. The critical idea here is that heuristics are not problematic per se, but they can become so when we treat them as laws by neglecting their rough and contingent nature. This principle may sound almost self-evident, but as our empirical evidence shows, at times it is more honoured in the breach than the observance. However, regardless of whether these ideals are met in practice, rule-based reasoning has certain intrinsic characteristics, strengths, and weaknesses, and tensions remain between the virtues served by relying on rules compared with those furthered by alternative species of reasoning (e.g.
factors-based judgments).
A concern with the rules of risk assessment raises questions for future research. One involves developing a set of criteria and methods for evaluating individual heuristics, and this seems in principle possible to do within a formal decision theoretic framework. (63) In the meantime, our present analysis has revealed the pervasive influence of heuristics in structuring formal risk assessment, and cast light on the significance of this for understanding and designing risk regulation regimes. 
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EPA's ule desig ati g Meth le e diphe l diiso a ate a high isk ai polluta t was challenged on various grounds. One was that the emission standard was based on the age 's default model, which assumed the substance would be emitted as a gas and disperse as such, when in fact it is solid at the (most) relevant temperatures, has a low vapour point, and typically disperses as an aerosol. The decision was overturned as the default, ge e i odel o e o atio al elatio ship to the ai polluta t i this ase.
The court acknowledged trade-off between accuracy and efficiency in risk assessment, but critiqued the EPA for rigid, unthinking adherence to default procedures for model selection (heuristics) when faced with overwhelming evidence that they were unsound in a particular instance. "e e al u io s halle ged O"HA's e issio sta da ds o fo aldeh de i the workplace as insufficiently stringent. Central issue was whether the agency adequately explained its reasons for departing from the default assumption of linearity at low doses for the carcinogen (the linearity heuristic). The rule was remanded.
Court held that the agency had not given a properly reasoned basis for departing from the heuristic, and so overturned the rule. As a subsidiary issue, court found no issue with the agency departing from another default rulewhen they favoured animal studies rather than epidemiological data in standard setting -on the grounds that this was a reasoned departure from the rule. For example, they cited difficulties in getting precise exposure data, and controlling for possible confounders, etc. E i o e tal g oups halle ged EPA's tole a es fo se e pesti ides.
In particular, they halle ged EPA's de iatio f o default safet fa to s (the back of the envelope heuristics) designed to be protective of infants and children for acetamiprid, mepiquat, and pymetrozine. The governing statute states that the EPA is allo ed to use a diffe e t a gi of safet fo the pesti ide he i al residue only if, on the basis of reliable data, such margin will be safe for infants a d hild e . However, the court found that the EPA had not clearly argued or articulated the link between the underlying toxicological evidence, and the (nondefault) safety factors that were ultimately adopted. The decision was remanded on this basis.
The dispute, as the court saw it, turned on whether the EPA's e ide e o stituted elia le data fo i fe i g that the lower margins of safety would be sufficiently protective. The agency had explicitly stated its reasoning behind deviating from (and lowering) its default safety factors when it set the tolerances (e.g. claiming data
showed no evidence of greater sensitivity to the young, nor of abnormalities in development of foetal nervous system).
However, the court found this inadequate, holding that the particular deviations -e.g. from a safety factor of 10 to one NRDC halle ged EPA's di hlo os isk assess e t o se e al g ou ds. The isk assessment itself had various components, with some relying on a study of human subjects (the Gledhill stud , a d so e el i g o a i al toxicology studies.
NRDC lai ed that the age 's depa tu e f o the p esu pti e te fold hild e 's safet fa to (the heuristic) was unsound. The court agreed in part, finding that in some components of the risk assessment the agency had failed to explicitly justify this departure. These portions of the risk assessment were vacated. By contrast, in the portions of the risk assessment that relied on animal studies, the EPA provided explicit reasons for departing from the default (e.g. o evidence for increased susceptibility of the rat and rabbit offspring to prenatal or post atal e posu e to di hlo os . These po tio s e e upheld.
A othe g ou ds fo NRDC's halle ge as that the EPA's elia e o the Gledhill study violated its own gatekeeping heuristic. The rule, which is restricted to pesticides regulation, forbids the EPA (and FDA) from relying on data from research on human subjects initiated prior to April 7, 2006 in cases where there is lea a d o i i g e ide e that the esea h as eithe :
Once more, (portions of) a risk assessment were overturned in court due to unreasoned departures from heuristics.
However, unreasoned here should be interpreted in the literal sense of a failure to provide explicit justifications, rather than necessarily being unwise.
The (unresolved) dispute over the gatekeeping rule is interesting in that it highlights the interpretive flexibility contained within linguistically formulated (rather than mathematical) rules.
[1] fundamentally unethical (e.g., the research was intended to seriously harm participants or failed to obtain informed consent), or [2] significantly deficient relative to the ethical standards prevailing at the time the esea h as o du ted.
This dispute turned on whether the human subjects could be considered to have given their informed consent. For example, in parts of the consent forms the pesticide was referred to as a drug. However, the EPA countered that its independent experts found the consent forms "clearly advised subjects that this as a stud i ol i g o su i g a i se ti ide. Court declined to resolve this dispute. Table 1 : Data showing contested or problematic applications of heuristics in agency decision making, drawn from judicial reviews.
